To systematically depict the TME of TSC2-loss NSCLC, we used the TIMER 2.0 to evaluate the association between TSC2 mRNA level and major immune cell subtypes by various algorithms. The gene discussed is TSC2; the disease is non-small cell lung carcinoma.